184 related articles for article (PubMed ID: 33593484)
1. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
Lehrer S; Rheinstein PH
Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
3. The β
Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
[TBL] [Abstract][Full Text] [Related]
5. ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects.
Messina Baas O; Pacheco Cuellar G; Toral-López J; Lara Huerta SF; Gonzalez-Huerta LM; Urueta-Cuellar H; Rivera-Vega MR; Babayan-Mena I; Cuevas-Covarrubias SA
Curr Eye Res; 2014 Nov; 39(11):1076-80. PubMed ID: 24749907
[TBL] [Abstract][Full Text] [Related]
6. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Torp-Pedersen C; Køber L; Poulsen HE
Pharmacogenet Genomics; 2012 Oct; 22(10):709-15. PubMed ID: 22760495
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma.
Inagaki Y; Mashima Y; Fuse N; Funayama T; Ohtake Y; Yasuda N; Murakami A; Hotta Y; Fukuchi T; Tsubota K
Mol Vis; 2006 Jun; 12():673-80. PubMed ID: 16785856
[TBL] [Abstract][Full Text] [Related]
8. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
[TBL] [Abstract][Full Text] [Related]
9. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Parolia A; Cieslik M; Chu SC; Xiao L; Ouchi T; Zhang Y; Wang X; Vats P; Cao X; Pitchiaya S; Su F; Wang R; Feng FY; Wu YM; Lonigro RJ; Robinson DR; Chinnaiyan AM
Nature; 2019 Jul; 571(7765):413-418. PubMed ID: 31243372
[TBL] [Abstract][Full Text] [Related]
10. beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Pacanowski MA; Gong Y; Cooper-Dehoff RM; Schork NJ; Shriver MD; Langaee TY; Pepine CJ; Johnson JA;
Clin Pharmacol Ther; 2008 Dec; 84(6):715-21. PubMed ID: 18615004
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.
Guerra LA; Lteif C; Arwood MJ; McDonough CW; Dumeny L; Desai AA; Cavallari LH; Duarte JD
Pharmacogenomics J; 2022 Feb; 22(1):62-68. PubMed ID: 34642472
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
13. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
Dai S; Ma W; Qin G; Wang L; Wang E
Clin Ther; 2021 Feb; 43(2):349-359.e2. PubMed ID: 33451866
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
Kim KM; Murray MD; Tu W; Robarge J; Ding Y; Brater DC; Flockhart DA
Eur J Clin Pharmacol; 2012 Nov; 68(11):1483-91. PubMed ID: 22543981
[TBL] [Abstract][Full Text] [Related]
15. Investigating changes in β-adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study.
Tutgun Onrat S; Dural İE; Yalım Z; Onrat E
Mol Biol Rep; 2021 Dec; 48(12):7893-7900. PubMed ID: 34716504
[TBL] [Abstract][Full Text] [Related]
16. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
17. β
Li Y; Yuan H; Sun L; Zhou Q; Yang F; Yang Z; Liu D
Genet Test Mol Biomarkers; 2019 Feb; 23(2):124-137. PubMed ID: 30668166
[TBL] [Abstract][Full Text] [Related]
18. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
20. Role of beta1-adrenoceptor in increased lipolysis in cancer cachexia.
Cao DX; Wu GH; Yang ZA; Zhang B; Jiang Y; Han YS; He GD; Zhuang QL; Wang YF; Huang ZL; Xi QL
Cancer Sci; 2010 Jul; 101(7):1639-45. PubMed ID: 20426789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
